[Epoch Times, July 22, 2021](Epoch Times reporter Li Yixin reported) The Central Epidemic Command Center announced on the 22nd that my country and Moderna have signed another 36 million doses of vaccine supply contract. The next-generation vaccine will be provided in batches the following year. Executive President Su Zhenchang said on the 22nd that the national vaccination rate increased to 23.5% on the 21st, and was originally scheduled to reach 25% by the end of July, and is now moving closer to the 30% target.
Taiwan has signed a contract for the supply of 5.05 million doses of COVID-19 (Chinese Communist virus) vaccine with Modena of the United States on February 8 this year. Currently, 1.15 million doses have been delivered. Minister of Health and Welfare Chen Shizhong stated at a press conference on the 22nd that he will sign a two-year contract with Modena Division for the supply of 35 million doses of next-generation COVID-19 vaccine, and purchase an additional 1 million doses of vaccine, which will be supplied in the fourth quarter of this year. People were vaccinated, and the two purchased a total of 36 million doses.
Chen Shizhong said that the command center is currently in the process of purchasing and obtaining next-generation vaccines simultaneously with Europe, America and Japan to meet the needs of future epidemics; it will supply prime series vaccines and next-generation booster vaccines in batches in 2022 and 2023. Vaccine candidate) to respond to the threat of mutated virus strains and to supply more population vaccination needs.
Executive Yuan spokesperson Luo Bingcheng also said that at present, the three private units donate 5 million doses, a total of 15 million doses of BNT vaccine. In addition, the domestic high-end vaccine also obtained emergency use authorization (EUA) on the 19th. The vaccine has new progress every week. Special thanks to the FDA and experts and scholars for their efforts to protect the health of the Chinese people based on science and professionalism, so that domestic vaccines can be used. There are new developments. ◇
Editor in charge: Lin Qinzhi
.